Calliditas Therapeutics AB (publ) (CALT) Institutional Ownership $40.00 0.00 (0.00%) As of 02/20/2025 Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Calliditas Therapeutics AB (publ) (NASDAQ:CALT)CurrentInstitutional OwnershipPercentage2.83%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$644.68KNumber ofInstitutional Sellers(last 12 months)0 Get CALT Insider Trade Alerts Want to know when executives and insiders are buying or selling Calliditas Therapeutics AB (publ) stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data CALT Institutional Buying and Selling by Quarter Calliditas Therapeutics AB (publ) Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/4/2024 Crossmark Global Holdings Inc.16,117$655K0.0%N/A0.054% 2/13/2024 Optiver Holding B.V.980$25K0.0%N/A0.003% 5/15/2023 Ironwood Investment Management LLC27,795$666K0.4%+5.6%0.093% 5/11/2023 Optiver Holding B.V.5,029$120K0.0%-54.9%0.017% 2/10/2023 Optiver Holding B.V.11,141$195K0.0%-11.8%0.037% 2/9/2023 HBK Sorce Advisory LLC90,000$104K0.0%+100.0%0.302% 1/31/2023 Ironwood Investment Management LLC26,309$447K0.3%-8.5%0.088% 11/14/2022 Optiver Holding B.V.12,625$191K0.0%+1,304.3%0.043% 11/14/2022 HBK Sorce Advisory LLC45,000$50K0.0%N/A0.152% 5/10/2022 Ironwood Investment Management LLC28,762$551K0.3%+5.5%0.110% 2/10/2022 Ironwood Investment Management LLC27,267$675K0.3%-2.0%0.104% 11/12/2021 Ironwood Investment Management LLC27,836$602K0.3%+75.2%0.106% 8/27/2021Endurant Capital Management LP144,393$4.25M1.2%+1.5%0.552% 8/12/2021 Advisory Services Network LLC3,369$99K0.0%N/A0.013% 8/11/2021 Deutsche Bank AG71,531$2.11M0.0%+1.8%0.286% 7/31/2021NEXT Financial Group Inc4,458$131K0.0%N/A0.018% 5/19/2021 Hillhouse Capital Advisors LTD.944,716$26.10M0.3%-9.8%3.783% 5/18/2021 Millennium Management LLC15,570$430K0.0%-24.0%0.062% 5/18/2021 Tudor Investment Corp Et Al13,782$380K0.0%N/A0.055% 5/18/2021 Citadel Advisors LLC9,571$264K0.0%N/A0.038% 5/17/2021Endurant Capital Management LP142,323$3.92M1.0%N/A0.570% 2/17/2021 Jane Street Group LLC7,557$256K0.0%-26.5%0.032% 2/13/2021 Hillhouse Capital Advisors LTD.1,047,687$35.61M0.3%+199.3%4.371% (Data available from 1/1/2016 forward) CALT Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CALT shares? During the previous two years, the following institutional investors and hedge funds held shares of Calliditas Therapeutics AB (publ) shares: Ironwood Investment Management LLC ($666K), and Crossmark Global Holdings Inc. ($655K), Optiver Holding B.V. ($25K).Learn more on CALT's institutional investors. What percentage of Calliditas Therapeutics AB (publ) stock is owned by institutional investors? 2.83% of Calliditas Therapeutics AB (publ) stock is owned by institutional investors. Learn more on CALT's institutional investor holdings. Which institutional investors have been buying Calliditas Therapeutics AB (publ) stock? The following institutional investors have purchased Calliditas Therapeutics AB (publ) stock in the last 24 months: Crossmark Global Holdings Inc. ($16.12K), Ironwood Investment Management LLC ($1.49K), and Optiver Holding B.V. ($980.00). How much institutional buying is happening at Calliditas Therapeutics AB (publ)? Institutional investors have bought a total of 18,583 shares in the last 24 months. This purchase volume represents approximately $705.53K in transactions. Which Calliditas Therapeutics AB (publ) major shareholders have been selling company stock? The following institutional investors have sold Calliditas Therapeutics AB (publ) stock in the last 24 months: Optiver Holding B.V. ($6.11K). How much institutional selling is happening at Calliditas Therapeutics AB (publ)? Institutional investors have sold a total of 6,112 shares in the last 24 months. This volume of shares sold represents approximately $146.50K in transactions. Related Companies Verona Pharma Major Shareholders Krystal Biotech Major Shareholders Ultragenyx Pharmaceutical Major Shareholders Avidity Biosciences Major Shareholders SpringWorks Therapeutics Major Shareholders ADMA Biologics Major Shareholders Organon & Co. Major Shareholders Biohaven Major Shareholders Alvotech Major Shareholders PTC Therapeutics Major Shareholders This page (NASDAQ:CALT) was last updated on 2/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon “obliterates” Bill Gates?All 10 of the world's biggest money managers follow my work, and the Pentagon, the FBI and Harvard professors ...Altimetry | SponsoredNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | Sponsored My 2025 AI BlueprintI first recommended Bitcoin at $300 in 2013 … before it went up 33,645%. Now, I am revealing my 2025 AI Blu...Weiss Ratings | SponsoredBetter than Bitcoin – and potentially more profitableThe world is obsessed with Bitcoin again... And for a good reason: It just soared beyond $100,000. Bitcoin ...Brownstone Research | SponsoredAmerica cannot power AIThere’s a fatal flaw at the heart of the AI revolution… With AI continuing to explode in popularity, tech c...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Calliditas Therapeutics AB (publ) Please log in to your account or sign up in order to add this asset to your watchlist. Share Calliditas Therapeutics AB (publ) With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
